A Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of LOXO-783 in Healthy Adult Subjects
Latest Information Update: 25 Jul 2024
At a glance
- Drugs LOXO-783 (Primary)
- Indications Breast cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
Most Recent Events
- 22 Jul 2024 Status changed from recruiting to completed.
- 11 Sep 2023 New trial record